These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19160313)

  • 21. Amphetamines for Attention Deficit Hyperactivity Disorder (ADHD) in adults.
    Castells X; Ramos-Quiroga JA; Bosch R; Nogueira M; Casas M
    Cochrane Database Syst Rev; 2011 Jun; (6):CD007813. PubMed ID: 21678370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. L-acetylcarnitine for treating fragile X syndrome.
    Rueda JR; Guillén V; Ballesteros J; Tejada MI; Solà I
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD010012. PubMed ID: 25985235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults.
    Najib J
    Clin Ther; 2009 Jan; 31(1):142-76. PubMed ID: 19243715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Effect of Vitamin D Supplementation on Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Gan J; Galer P; Ma D; Chen C; Xiong T
    J Child Adolesc Psychopharmacol; 2019 Nov; 29(9):670-687. PubMed ID: 31368773
    [No Abstract]   [Full Text] [Related]  

  • 25. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
    Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current and Investigational Medication Delivery Systems for Treating Attention-Deficit/Hyperactivity Disorder.
    Jain R; Katic A
    Prim Care Companion CNS Disord; 2016 Aug; 18(4):. PubMed ID: 27828696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis.
    Elliott J; Johnston A; Husereau D; Kelly SE; Eagles C; Charach A; Hsieh SC; Bai Z; Hossain A; Skidmore B; Tsakonas E; Chojecki D; Mamdani M; Wells GA
    PLoS One; 2020; 15(10):e0240584. PubMed ID: 33085721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of stimulants and atomoxetine on emotional lability in adults: A systematic review and meta-analysis.
    Moukhtarian TR; Cooper RE; Vassos E; Moran P; Asherson P
    Eur Psychiatry; 2017 Jul; 44():198-207. PubMed ID: 28646732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Social skills training for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.
    Storebø OJ; Skoog M; Damm D; Thomsen PH; Simonsen E; Gluud C
    Cochrane Database Syst Rev; 2011 Dec; (12):CD008223. PubMed ID: 22161422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of psychostimulants on brain structure and function in ADHD: a qualitative literature review of magnetic resonance imaging-based neuroimaging studies.
    Spencer TJ; Brown A; Seidman LJ; Valera EM; Makris N; Lomedico A; Faraone SV; Biederman J
    J Clin Psychiatry; 2013 Sep; 74(9):902-17. PubMed ID: 24107764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of Irritability With Psychostimulant Treatment in Children With ADHD: A Meta-Analysis.
    Stuckelman ZD; Mulqueen JM; Ferracioli-Oda E; Cohen SC; Coughlin CG; Leckman JF; Bloch MH
    J Clin Psychiatry; 2017 Jun; 78(6):e648-e655. PubMed ID: 28682529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.
    Goldman LS; Genel M; Bezman RJ; Slanetz PJ
    JAMA; 1998 Apr; 279(14):1100-7. PubMed ID: 9546570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and Safety of SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled, Forced-Dose Clinical Study.
    Weisler RH; Greenbaum M; Arnold V; Yu M; Yan B; Jaffee M; Robertson B
    CNS Drugs; 2017 Aug; 31(8):685-697. PubMed ID: 28712074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Effects of Long-Acting Stimulant and Nonstimulant Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Meta-Analysis of Randomized Controlled Trials.
    Cerrillo-Urbina AJ; García-Hermoso A; Pardo-Guijarro MJ; Sánchez-López M; Santos-Gómez JL; Martínez-Vizcaíno V
    J Child Adolesc Psychopharmacol; 2018 Oct; 28(8):494-507. PubMed ID: 29897263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Phase 3, Randomized Double-Blind Study of the Efficacy and Safety of Low-Dose SHP465 Mixed Amphetamine Salts Extended-Release in Children with Attention-Deficit/Hyperactivity Disorder.
    Mattingly G; Arnold V; Yan B; Yu M; Robertson B
    J Child Adolesc Psychopharmacol; 2020 Nov; 30(9):549-557. PubMed ID: 33185468
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis with focus on bupropion.
    Stuhec M; Munda B; Svab V; Locatelli I
    J Affect Disord; 2015 Jun; 178():149-59. PubMed ID: 25813457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychostimulant treatment of adults with mental retardation and attention-deficit hyperactivity disorder.
    Jou R; Handen B; Hardan A
    Australas Psychiatry; 2004 Dec; 12(4):376-9. PubMed ID: 15715811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current pharmacotherapy of attention deficit hyperactivity disorder.
    Reddy DS
    Drugs Today (Barc); 2013 Oct; 49(10):647-65. PubMed ID: 24191257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stimulant drug effects on attention deficit/hyperactivity disorder: a review of the effects of age and sex of patients.
    Cornforth C; Sonuga-Barke E; Coghill D
    Curr Pharm Des; 2010; 16(22):2424-33. PubMed ID: 20513225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of psychiatric comorbidities with the risk of transport accidents in ADHD and MPH.
    Liu YC; Chen VC; Yang YH; Chen YL; Gossop M
    Epidemiol Psychiatr Sci; 2021 Feb; 30():e14. PubMed ID: 33583471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.